S. Szatmári

发表

Mannitol Use in Acute Stroke: Case Fatality at 30 Days and 1 Year

L. Csiba, D. Bereczki, I. Fekete, 2003, Stroke.

Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke

P. Rothwell, J. Wardlaw, P. Bath, 2019, Stroke.

Vinpocetine for cognitive impairment and dementia.

P. Whitehouse, S. Szatmári, Peter J. Whitehouse, 2003, The Cochrane database of systematic reviews.

NDT_A_200360 1287..1310

M. Siepmann, T. Siepmann, A. I. Penzlin, 2019 .

The role of ultrasound in the diagnosis of temporal arteritis.

S. Szatmári, Anca Moţăţăianu, Z. Bajko, 2015, Neurologia i neurochirurgia polska.

Prestroke alcohol consumption and smoking are not associated with stroke severity, disability at discharge, and case fatality.

L. Csiba, D. Bereczki, L. Mihálka, 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Relationship between nitrate headache and outcome in patients with acute stroke: results from the efficacy of nitric oxide in stroke (ENOS) trial

S. Pocock, J. Wardlaw, S. Phillips, 2020, Stroke and vascular neurology.

Route of Feeding as a Proxy for Dysphagia After Stroke and the Effect of Transdermal Glyceryl Trinitrate: Data from the Efficacy of Nitric Oxide in Stroke Randomised Controlled Trial

S. Hamdy, V. Caso, S. Phillips, 2017, Translational Stroke Research.

Central adjudication of serious adverse events did not affect trial’s safety results: Data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial

Rónán Collins, Alan A Montgomery, John Gommans, 2018, PloS one.

Common Carotid Artery Occlusion: A Case Series

S. Szatmári, Anca Moţăţăianu, Z. Bajko, 2013, ISRN neurology.

Cutaneous Autonomic Pilomotor Testing to Unveil the Role of Neuropathy Progression in Early Parkinson’s Disease (CAPTURE PD): Protocol for a Multicenter Study

R. Freeman, H. Reichmann, A. Lipp, 2017, Front. Neurol..

Profile Of Patients With Advanced Parkinson’s disease Suitable For Device-Aided Therapies: Restrospective Data Of A Large Cohort Of Romanian Patients

K. Orbán-Kis, S. Szatmári, V. Constantin, 2019, Neuropsychiatric disease and treatment.

[The role of selective monoamine oxidase B inhibitors in the therapeutic strategy of Parkinson's disease in the neurology clinics of Tirgu Mures County Emergency Clinical Hospital].

S. Szatmári, Eszter Blényesi, V. Constantin, 2017, Orvosi hetilap.

Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: Observations and Dilemmas after 10 Years of Real-Life Experience

K. Orbán-Kis, S. Szatmári, M. Simu, 2022, Pharmaceutics.

Management Challenges of Severe, Complex Dyskinesia. Data from a Large Cohort of Patients Treated with Levodopa-Carbidopa Intestinal Gel for Advanced Parkinson’s Disease

K. Orbán-Kis, S. Szatmári, M. Simu, 2021, Brain sciences.

Levodopa-Carbidopa Intestinal Gel Infusion Therapy Discontinuation: A Ten-Year Retrospective Analysis of 204 Treated Patients

K. Orbán-Kis, S. Szatmári, A. Cornea, 2020, Neuropsychiatric disease and treatment.

Incomplete Locked-in Syndrome

S. Szatmári, Z. Bajko, Timea Szilagyi, 2011, Romanian Journal of Neurology.

Glyceryl Trinitrate for Acute Intracerebral Hemorrhage: Results From the Efficacy of Nitric Oxide in Stroke (ENOS) Trial, a Subgroup Analysis

S. Pocock, J. Wardlaw, L. Cala, 2016, Stroke.

The efficacy of nitric oxide in stroke (ENOS) trial – where do we stand in Romania?

P. Bath, S. Szatmári, Cheryl Renton, 2012, Romanian Journal of Neurology.

Linking Individual Patient Data to Estimate Incidence and Prevalence of Parkinson's Disease by Comparing Reports of Neurological Services and Pharmacy Prescription Refills at a Nationwide Level

A. Takáts, D. Bereczki, S. Szatmári, 2019, Front. Neurol..

A Rare Case of Histopathologically Confirmed Creutzfeldt–Jakob Disease from Romania, Long Route to Diagnosis—Case Report and an Overview of the Romanian CJD Situation

S. Szatmári, J. Szász, Attila Kövecsi, 2022, Journal of clinical medicine.

Therapeutic strategies in the early stages of Parkinson’s disease: a cross-sectional evaluation of 15 years’ experience with a large cohort of Romanian patients

K. Orbán-Kis, S. Szatmári, V. Constantin, 2019, Neuropsychiatric disease and treatment.

Imaging markers of small vessel disease and brain frailty, and outcomes in acute stroke

J. Wardlaw, L. Cala, A. Adami, 2019, Neurology.

Neuropsychiatric symptoms in untreated Parkinson’s disease

A. Takáts, T. Siepmann, B. Illigens, 2017, Neuropsychiatric disease and treatment.

Association of Restless Legs Syndrome With Incident Parkinson's Disease

K. Kalantar-Zadeh, C. Kovesdy, M. Molnar, 2017, Sleep.

The impact of SARS-CoV-2 infection on the outcome of acute ischemic stroke—A retrospective cohort study

T. Siepmann, D. Bereczki, B. Gunda, 2023, PloS one.

It is safe to use transdermal glyceryl trinitrate to lower blood pressure in patients with acute ischaemic stroke with carotid stenosis

J. Wardlaw, V. Caso, Yongjun Wang, 2019, Stroke and Vascular Neurology.

Continuing versus Stopping Prestroke Antihypertensive Therapy in Acute Intracerebral Hemorrhage: A Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke Trial

J. Wardlaw, L. Cala, A. Adami, 2016, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Subcortical features and cognitive performance in Hungarian cerebrovascular outpatients

L. Csiba, D. Bereczki, I. Fekete, 2002, Journal of the Neurological Sciences.

Screening of vascular cognitive impairment on a Hungarian cohort

L. Csiba, D. Bereczki, I. Fekete, 1999, Psychiatry and clinical neurosciences.

Factors influencing hemorrhagic transformation in ischemic stroke: a clinicopathological comparison

L. Csiba, D. Bereczki, L. Kerényi, 2006, European journal of neurology.

Two‐Year observational study of autonomic skin function in patients with Parkinson's disease compared to healthy individuals

R. Freeman, H. Reichmann, A. Takáts, 2023, European journal of neurology.

The prevalence of psychiatric symptoms before the diagnosis of Parkinson’s disease in a nationwide cohort: A comparison to patients with cerebral infarction

D. Bereczki, S. Szatmári, A. Ajtay, 2020, PloS one.

Effect of continuing versus stopping pre-stroke antihypertensive agents within 12 h on outcome after stroke: A subgroup analysis of the efficacy of nitric oxide in stroke (ENOS) trial

J. Wardlaw, V. Caso, L. Everton, 2022, EClinicalMedicine.

[Characteristics of levodopa treatment in advanced Parkinson's disease in the experiences of the neurology clinics of Târgu Mureș, Romania].

K. Orbán-Kis, S. Szatmári, V. Constantin, 2019, Orvosi hetilap.

Procaine treatments for cognition and dementia.

D. Bereczki, S. Szatmári, 2008, The Cochrane database of systematic reviews.

Treatment of dementia and cognitive impairment: What can we learn from the Cochrane Library

Dániel Bereczki, D. Bereczki, S. Szatmári, 2009, Journal of the Neurological Sciences.

Starting with 24-h levodopa carbidopa intestinal gel at initiation in a large cohort of advanced Parkinson’s disease patients

K. Orbán-Kis, S. Szatmári, V. Constantin, 2024, Scientific reports.

Levodopa–Entacapone–Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease: A Single Center Real-World Experience

K. Orbán-Kis, S. Szatmári, V. Constantin, 2024, Pharmaceutics.